Amendment: SEC Form SC 13D/A filed by Invesco California Value Municipal Income Trust
| INVESCO CALIFORNIA VALUE MUNICIPAL INCOME TRUST | 
| (Name of Issuer) | 
| Series 2015/6-VCV Variable Rate Muni Term Preferred Shares | 
| (Title of Class of Securities) | 
| 46132H601 | 
| (CUSIP Number) | 
| Bank of America Corporation Bank of America Corporate Center 100 N. Tryon Street Charlotte, North Carolina 28255 | 
| (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) | 
| June 10, 2020 | 
| (Date of Event which Requires Filing of this Statement) | 
| 1 | NAMES OF REPORTING PERSONS |  |  | ||
| Bank of America Corporation 56-0906609 |  |  | |||
|  |  | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) | ☐ | ||
| (b) | ☒ | ||||
|  |  | ||||
| 3 | SEC USE ONLY |  |  | ||
|  |  | ||||
|  |  | ||||
| 4 | SOURCE OF FUNDS (SEE INSTRUCTIONS) |  |  | ||
| WC |  |  | |||
|  |  | ||||
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E) |  | ☒ | ||
|  |  | ||||
|  |  | ||||
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION |  |  | ||
| Delaware |  |  | |||
|  |  | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER |  |  | |
| 0 |  |  | |||
|  |  | ||||
| 8 | SHARED VOTING POWER |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 9 | SOLE DISPOSITIVE POWER |  |  | ||
| 0 |  |  | |||
|  |  | ||||
| 10 | SHARED DISPOSITIVE POWER |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |  | ☐ | ||
|  |  | ||||
|  |  | ||||
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |  |  | ||
| 100%* |  |  | |||
|  |  | ||||
| 14 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |  |  | ||
| HC |  |  | |||
|  |  | ||||
| 1 | NAMES OF REPORTING PERSONS |  |  | ||
| Banc of America Preferred Funding Corporation 75-2939570 |  |  | |||
|  |  | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) | ☐ | ||
| (b) | ☒ | ||||
|  |  | ||||
| 3 | SEC USE ONLY |  |  | ||
|  |  |  | |||
|  |  | ||||
| 4 | SOURCE OF FUNDS (SEE INSTRUCTIONS) |  |  | ||
| WC |  |  | |||
|  |  | ||||
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E) |  | ☐ | ||
|  |  | ||||
|  |  | ||||
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION |  |  | ||
| Delaware |  |  | |||
|  |  | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER |  |  | |
| 0 |  |  | |||
|  |  | ||||
| 8 | SHARED VOTING POWER |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 9 | SOLE DISPOSITIVE POWER |  |  | ||
| 0 |  |  | |||
|  |  | ||||
| 10 | SHARED DISPOSITIVE POWER |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |  |  | ||
| 1,770 |  |  | |||
|  |  | ||||
| 12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |  | ☐ | ||
|  |  | ||||
|  |  | ||||
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |  |  | ||
| 100%* |  |  | |||
|  |  | ||||
| 14 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |  |  | ||
| CO |  |  | |||
|  |  | ||||
| Item 2. | Identity and Background | 
| Item 5. | Interest in Securities of the Issuer | 
| Item 7. | Material to be Filed as Exhibits | 
| Exhibit No. | Description | |
| Joint Filing Agreement, dated as of December 13, 2024, by and among the Reporting Persons. | 
| Date: December 13, 2024. | ||
| BANK OF AMERICA CORPORATION | ||
| By: | /s/ Andres Ortiz | |
| Name: Andres Ortiz | ||
| Title: Authorized Signatory | ||
| BANC OF AMERICA PREFERRED FUNDING CORPORATION | ||
| By: | /s/ Andres Ortiz | |
| Name: Andres Ortiz | ||
| Title: Authorized Signatory | ||
| Name | Position with Bank of America Corporation | Principal Occupation | ||
| Brian T. Moynihan | Chairman of the Board, Chief Executive Officer and Director | Chairman of the Board and Chief Executive Officer of Bank of America Corporation | ||
| Paul M. Donofrio | Vice Chair | Vice Chair of Bank of America Corporation | ||
| Thong M. Nguyen | Vice Chair, Head of Global Strategy & Enterprise Platforms | Vice Chair, Head of Global Strategy & Enterprise Platforms of Bank of America Corporation | ||
| Bruce R. Thompson | Vice Chair, Head of Enterprise Credit | Vice Chair, Head of Enterprise Credit of Bank of America Corporation | ||
| Dean C. Athanasia | President, Regional Banking | President, Regional Banking of Bank of America Corporation | ||
| James P. DeMare | President, Global Markets | President, Global Markets of Bank of America Corporation | ||
| Kathleen A. Knox | President, The Private Bank | President, The Private Bank of Bank of America Corporation | ||
| Matthew M. Koder | President, Global Corporate and Investment Banking | President, Global Corporate and Investment Banking of Bank of America Corporation | ||
| Bernard A. Mensah | President, International; CEO, Merrill Lynch International | President, International of Bank of America Corporation and CEO, Merrill Lynch International | ||
| Lindsay DeNardo Hans | President, Co-Head Merrill Wealth Management | President, Co-Head Merrill Wealth Management of Bank of America Corporation | ||
| Eric Schimpf | President, Co-Head Merrill Wealth Management | President, Co-Head Merrill Wealth Management of Bank of America Corporation | ||
| Aditya Bhasin | Chief Technology and Information Officer | Chief Technology and Information Officer of Bank of America Corporation | ||
| D. Steve Boland | Chief Administrative Officer | Chief Administrative Officer of Bank of America Corporation | ||
| Alastair Borthwick | Chief Financial Officer | Chief Financial Officer of Bank of America Corporation | ||
| Sheri Bronstein | Chief Human Resources Officer | Chief Human Resources Officer of Bank of America Corporation | ||
| Geoffrey Greener | Chief Risk Officer | Chief Risk Officer of Bank of America Corporation | ||
| Thomas M. Scrivener | Chief Operations Executive | Chief Operations Executive of Bank of America Corporation | ||
| Lauren A. Mogensen | Global General Counsel | Global General Counsel of Bank of America Corporation | ||
| Lionel L. Nowell, III | Lead Independent Director | Lead Independent Director, Bank of America Corporation; Former Senior Vice President and Treasurer, PepsiCo, Inc. | ||
| Sharon L. Allen | Director | Former Chairman, Deloitte LLP | ||
| Jose E. Almeida | Director | Chairman, President and Chief Executive Officer of Baxter International Inc. | ||
| Pierre J.P. de Weck1 | Director | Former Chairman and Global Head of Private Wealth Management, Deutsche Bank AG | ||
| Arnold W. Donald | Director | Former President and Chief Executive Officer, Carnival Corporation & Carnival plc | ||
| Linda P. Hudson | Director | Former Executive Officer, The Cardea Group, LLC and Former President and Chief Executive Officer of BAE Systems, Inc. | ||
| Monica C. Lozano | Director | Lead Independent Director, Target Corporation; Former Chief Executive Officer, Former College Futures Foundation and Former Chairman, US Hispanic Media Inc. | ||
| Denise L. Ramos | Director | Former Chief Executive Officer and President of ITT Inc. | ||
| Clayton S. Rose | Director | Baker Foundation Professor of Management Practice at Harvard Business School | ||
| Michael D. White | Director | Former Chairman, President, and Chief Executive Officer of DIRECTV | ||
| Thomas D. Woods2 | Director | Former Vice Chairman and Senior Executive Vice President of Canadian Imperial Bank of Commerce; Former Chairman, Hydro One Limited | ||
| Maria T. Zuber | Director | Vice President for Research and E.A., Griswold Professor of Geophysics, MIT | 
| Name | Position with Banc of America Preferred Funding Corporation | Principal Occupation | ||
| John J. Lawlor | Director and President | Managing Director, Municipal Markets and Public Sector Banking Executive of BofA Securities, Inc. and Bank of America, National Association | ||
| James Duffy | Managing Director | Director; MBAM BFO, The CFO Group of Bank of America, National Association | ||
| Michael I. Jentis | Managing Director | Managing Director, Head of Sales – Public Finance of BofA Securities, Inc. and Bank of America, National Association | ||
| Mona Payton | Managing Director | Managing Director, Municipal Markets Executive for Short-Term Trading of BofA Securities, Inc. and Bank of America, National Association | ||
| Edward J. Sisk | Director and Managing Director | Managing Director, Public Finance Executive of BofA Securities, Inc. and Bank of America, National Association | ||
| John B. Sprung | Director | Corporate Director | ||
| David A. Stephens | Director and Managing Director | Managing Director, Executive for Public Finance and Public Sector Credit Products of BofA Securities, Inc. and Bank of America, National Association | 
| TRADE DATE | BUY/SELL | QUANTITY | PRICE | EXECUTION | |||||||
| 06/10/2020 | B | 216 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 251 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 200 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 48 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 200 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 261 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | B | 100 | $ | 11.65 | NYSE | ||||||
| 06/10/2020 | S | 216 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 261 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 200 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 251 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 100 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 48 | $ | 11.65 | OTC | ||||||
| 06/10/2020 | S | 200 | $ | 11.65 | OTC | ||||||
| 08/14/2020 | B | 6,000 | $ | 12.6661 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 99 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 99 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 35 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 99 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 99 | $ | 12.07 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 300 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 1,000 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 405 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 99 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 96 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.05 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 20 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 80 | $ | 12.06 | OTC | ||||||
| 08/27/2020 | S | 300 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 16 | $ | 12.04 | OTC | ||||||
| 08/27/2020 | S | 284 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 200 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 300 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 300 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 100 | $ | 12.03 | OTC | ||||||
| 08/27/2020 | S | 69 | $ | 12.03 | OTC | ||||||
| 09/03/2020 | S | 2,300 | $ | 12.58 | OTC | ||||||
| 09/03/2020 | S | 7,000 | $ | 12.58 | OTC | ||||||
| 09/08/2020 | B | 2,300 | $ | 12.4 | OTC | ||||||
| 09/08/2020 | B | 431 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 400 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 300 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 200 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 277 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 23 | $ | 12.43 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 600 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 567 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 200 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 400 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 300 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 600 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.44 | OTC | ||||||
| 09/08/2020 | B | 300 | $ | 12.45 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.45 | OTC | ||||||
| 09/08/2020 | B | 200 | $ | 12.45 | OTC | ||||||
| 09/08/2020 | B | 2 | $ | 12.46 | OTC | ||||||
| 09/08/2020 | B | 100 | $ | 12.46 | OTC | ||||||
| 09/08/2020 | B | 200 | $ | 12.46 | OTC | ||||||
| 09/08/2020 | B | 200 | $ | 12.46 | OTC | ||||||
| 09/17/2020 | S | 50 | $ | 12.4332 | OTC | ||||||
| 09/21/2020 | B | 50 | $ | 12.48 | OTC | ||||||
| 04/16/2021 | S | 208 | $ | 13.185 | OTC | ||||||
| 04/19/2021 | B | 208 | $ | 13.1954 | OTC | ||||||
| 06/11/2021 | S | 50 | $ | 13.8408 | OTC | ||||||
| 06/14/2021 | B | 50 | $ | 13.75 | OTC | ||||||
| 11/17/2022 | S | 2,000 | $ | 9.2 | OTC | ||||||
| 12/05/2022 | B | 100 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 291 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 69 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 219 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 167 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 100 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 132 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 54 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 100 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 59 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | B | 200 | $ | 10.04 | NYSE | ||||||
| 12/05/2022 | S | 69 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 167 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 291 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 200 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 100 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 219 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 100 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 59 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 54 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 132 | $ | 10.04 | OTC | ||||||
| 12/05/2022 | S | 100 | $ | 10.04 | OTC | ||||||
| 12/27/2022 | B | 1,813 | $ | 9.38 | OTC | ||||||
| 12/27/2022 | B | 187 | $ | 9.38 | OTC | ||||||
| 06/05/2023 | B | 499 | $ | 9.38 | OTC | ||||||
| 06/05/2023 | S | 100 | $ | 9.4 | AMEX | ||||||
| 06/05/2023 | S | 100 | $ | 9.4 | OTC | ||||||
| 06/05/2023 | S | 43 | $ | 9.4 | AMEX | ||||||
| 06/05/2023 | S | 6 | $ | 9.4 | AMEX | ||||||
| 06/05/2023 | S | 100 | $ | 9.42 | OTC | ||||||
| 06/05/2023 | S | 25 | $ | 9.42 | AMEX | ||||||
| 06/05/2023 | S | 31 | $ | 9.42 | AMEX | ||||||
| 06/05/2023 | S | 51 | $ | 9.42 | OTC | ||||||
| 06/05/2023 | S | 43 | $ | 9.44 | NYSE | ||||||
| 06/05/2023 | B | 1,583 | $ | 9.39 | NYSE | ||||||
| 06/05/2023 | S | 1,583 | $ | 9.39 | OTC | ||||||
| 06/12/2023 | B | 469 | $ | 9.51 | OTC | ||||||
| 06/13/2023 | S | 469 | $ | 9.555 | OTC | ||||||
| 12/13/2023 | B | 900 | $ | 9.58 | OTC | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 154 | $ | 9.725 | AMEX | ||||||
| 12/15/2023 | S | 46 | $ | 9.72 | NYSE | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 21 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 100 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 21 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 21 | $ | 9.725 | OTC | ||||||
| 12/15/2023 | S | 21 | $ | 9.725 | AMEX | ||||||
| 12/15/2023 | S | 16 | $ | 9.725 | AMEX | ||||||
| 09/19/2024 | S | 3,477 | $ | 10.963 | OTC | ||||||
| 09/19/2024 | B | 137 | $ | 11.0 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 11.0 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 400 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 11.0 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 11.0 | OTC | ||||||
| 09/19/2024 | B | 400 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 300 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 500 | $ | 11.0 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 200 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 400 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 100 | $ | 10.99 | OTC | ||||||
| 09/19/2024 | B | 40 | $ | 10.99 | OTC | ||||||
| TRADE DATE | BUY/SELL | QUANTITY | PRICE | EXECUTION | 
| 04/12/2022 | B | 1,000 | 100% | OTC |